HUP0202974A2 - Fémtartalmú ribonukleotid-polipeptidek - Google Patents
Fémtartalmú ribonukleotid-polipeptidekInfo
- Publication number
- HUP0202974A2 HUP0202974A2 HU0202974A HUP0202974A HUP0202974A2 HU P0202974 A2 HUP0202974 A2 HU P0202974A2 HU 0202974 A HU0202974 A HU 0202974A HU P0202974 A HUP0202974 A HU P0202974A HU P0202974 A2 HUP0202974 A2 HU P0202974A2
- Authority
- HU
- Hungary
- Prior art keywords
- polypeptides
- ribonucleotide polypeptides
- contain
- metal
- ribonucleotide
- Prior art date
Links
- 108091028664 Ribonucleotide Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000002336 ribonucleotide Substances 0.000 title abstract 4
- 125000002652 ribonucleotide group Chemical group 0.000 title abstract 4
- 239000002184 metal Substances 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- QUQFTIVBFKLPCL-UHFFFAOYSA-L copper;2-amino-3-[(2-amino-2-carboxylatoethyl)disulfanyl]propanoate Chemical compound [Cu+2].[O-]C(=O)C(N)CSSCC(N)C([O-])=O QUQFTIVBFKLPCL-UHFFFAOYSA-L 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000263 nonmitogenic effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány biológiailag aktív, réz-, cink- vagy kalciumtartalmúribonukleotid-polipeptidekre (RNP), valamint ezek előállításieljárására, alkalmazására, és olyan gyógyászati készítményekrevonatkozik, amelyek ribonukleotid-polipeptideket, illetveribonukleotid-polipeptidek elleni antitesteket és/vagy ezekkelmolekuláris biológiai szempontból ekvivalens szerkezeteket és/vagyrészeket és/vagy származékokat tartalmaznak. A találmány szerintivegyületek meghatározott nukleinsav-szekvenciával rendelkeznek,speciálisan a vérér in vivo és in vitro képződését képesek kiváltani,és az angiogenézisnek illetve, a vérércsíra iránynövekedésénekbiológiailag specifikus, természetesen ható nemmitogén mediátorai. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19525992 | 1995-07-17 | ||
| DE19530500 | 1995-08-18 | ||
| PCT/DE1996/001337 WO1997004007A2 (de) | 1995-07-17 | 1996-07-17 | Metallhaltige ribonukleotidpolypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202974A2 true HUP0202974A2 (hu) | 2002-12-28 |
| HUP0202974A3 HUP0202974A3 (en) | 2005-05-30 |
Family
ID=26016878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202974A HUP0202974A3 (en) | 1995-07-17 | 1996-07-17 | Metal-containing ribonucleotide polypeptides |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6087123A (hu) |
| EP (1) | EP0781294A1 (hu) |
| AU (1) | AU6698496A (hu) |
| CA (1) | CA2196802A1 (hu) |
| CZ (1) | CZ75597A3 (hu) |
| DE (1) | DE19628895A1 (hu) |
| HU (1) | HUP0202974A3 (hu) |
| WO (1) | WO1997004007A2 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19810998C1 (de) * | 1998-03-13 | 1999-08-26 | Fraunhofer Ges Forschung | Metallhaltige Ribonukleotidpolypeptide |
| DE19811047C1 (de) | 1998-03-13 | 1999-04-15 | Fraunhofer Ges Forschung | Metallhaltige Ribonukleotidpolypeptide |
| DE10109466B4 (de) * | 2001-02-28 | 2008-01-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren und Mittel zur Modifikation humaner Angiogenese |
| UA91205C2 (ru) * | 2004-12-17 | 2010-07-12 | Венус Ремедиз Лимитед | Антибиотическая комбинация амикацина и цефепима для создания общего раствора для лечения инфекций |
| AU2006213441B2 (en) * | 2005-02-14 | 2011-12-01 | Venus Remedies Limited | Parenteral combination therpy for infective conditions with drug resistant bacterium |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TW202330904A (zh) | 2015-08-04 | 2023-08-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
-
1996
- 1996-07-17 CA CA002196802A patent/CA2196802A1/en not_active Abandoned
- 1996-07-17 EP EP96926996A patent/EP0781294A1/de not_active Withdrawn
- 1996-07-17 US US08/794,000 patent/US6087123A/en not_active Expired - Fee Related
- 1996-07-17 DE DE19628895A patent/DE19628895A1/de not_active Ceased
- 1996-07-17 AU AU66984/96A patent/AU6698496A/en not_active Abandoned
- 1996-07-17 WO PCT/DE1996/001337 patent/WO1997004007A2/de not_active Application Discontinuation
- 1996-07-17 HU HU0202974A patent/HUP0202974A3/hu unknown
- 1996-07-17 CZ CZ97755A patent/CZ75597A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE19628895A1 (de) | 1997-01-23 |
| HUP0202974A3 (en) | 2005-05-30 |
| CA2196802A1 (en) | 1997-02-06 |
| WO1997004007A3 (de) | 1997-03-13 |
| AU6698496A (en) | 1997-02-18 |
| EP0781294A1 (de) | 1997-07-02 |
| US6087123A (en) | 2000-07-11 |
| WO1997004007A2 (de) | 1997-02-06 |
| CZ75597A3 (en) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA96503B (en) | Stable-lipid-comprising drug delivery complexes and methods for their production | |
| ES2170755T3 (es) | Conjugados de farmaco antitumoral escindibles por enzimas lisosomales. | |
| DE69029657D1 (de) | Menschliches cytokin, interleukin-9 | |
| WO2001036640A3 (en) | Human fgf-21 gene and gene expression products | |
| AU3936697A (en) | Large scale production of human or animal proteins using plant bioreactors | |
| ATE295745T1 (de) | Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material | |
| EA199900861A1 (ru) | Усеченные белки, родственные фактору роста эндотелия сосудов | |
| WO1995021919A3 (en) | Protein having tpo activity | |
| ATE234919T1 (de) | Antisense nukleinsäuren zur vorbeugung und behandlung von beschwerden in welchen die exprimierung von c-erbb-2 eine rolle spielt | |
| WO1988007576A3 (fr) | Proteines vasculaires anticoagulantes, leurs adn de codage, production et utilisation | |
| ATE17858T1 (de) | Angiotropine aus leukozyten und entzuendeten geweben: eine neue klasse von natuerlichen chemotropischen und mitogenen proteinen fuer die spezifische induktion des gesteuerten wachstums von blutgefaessen, fuer neue gefaessbildung von geweben und fuer die morphogenese von blutgefaessverzweigungen; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen. | |
| HUP0103465A2 (hu) | A VEGF expressziójának gátlására szolgáló rövid oligonukleotidok | |
| NZ223867A (en) | Platelet-derived growth factor b chain (pdgf b), monoclonal antibodies to it, purification of it using the antibodies, production using genetic engineering and pharmaceuticals | |
| WO1995025171A3 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
| AU2503788A (en) | Process for the production of biodegradable microcapsules of water-soluble peptides and proteins, and microcapsules obtained by this process | |
| DE3271862D1 (en) | Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions | |
| HUP0202974A2 (hu) | Fémtartalmú ribonukleotid-polipeptidek | |
| CA2032167A1 (en) | Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene | |
| EP0302303A3 (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
| DE69326050T2 (de) | Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure | |
| DE69920216D1 (de) | Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren | |
| UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання | |
| WO2001042448A3 (en) | Artificial promoters for protein expression in plants | |
| DE3680329D1 (de) | Methode zur herstellung von dekorativen emblemen und dergleichen sowie auf diese weise hergestellte gegenstaende. | |
| WO1999010015A3 (de) | Verfahren zum herstellen von weitgehend nebenwirkungsfreien kontrastmitteln |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |